These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9269216)

  • 1. Measurement of acetylcholinesterase by positron emission tomography in the brains of healthy controls and patients with Alzheimer's disease.
    Iyo M; Namba H; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
    Lancet; 1997 Jun; 349(9068):1805-9. PubMed ID: 9269216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positron emission tomographic measurement of brain acetylcholinesterase activity using N-[(11)C]methylpiperidin-4-yl acetate without arterial blood sampling: methodology of shape analysis and its diagnostic power for Alzheimer's disease.
    Tanaka N; Fukushi K; Shinotoh H; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Ota T; Tanada S; Irie T
    J Cereb Blood Flow Metab; 2001 Mar; 21(3):295-306. PubMed ID: 11295884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dementia with Lewy bodies can be well-differentiated from Alzheimer's disease by measurement of brain acetylcholinesterase activity-a [11C]MP4A PET study.
    Shimada H; Hirano S; Sinotoh H; Ota T; Tanaka N; Sato K; Yamada M; Fukushi K; Irie T; Zhang MR; Higuchi M; Kuwabara S; Suhara T
    Int J Geriatr Psychiatry; 2015 Nov; 30(11):1105-13. PubMed ID: 26280153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of [(11)C]MP4A using a high-radioactivity brain region that represents an integrated input function for measurement of cerebral acetylcholinesterase activity without arterial blood sampling.
    Nagatsuka Si S; Fukushi K; Shinotoh H; Namba H; Iyo M; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
    J Cereb Blood Flow Metab; 2001 Nov; 21(11):1354-66. PubMed ID: 11702050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A simple method for the detection of abnormal brain regions in Alzheimer's disease patients using [11C]MP4A: comparison with [123I]IMP SPECT.
    Ota T; Shinotoh H; Fukushi K; Nagatsuka S; Namba H; Iyo M; Aotsuka A; Tanaka N; Sato K; Shiraishi T; Tanada S; Arai H; Irie T
    Ann Nucl Med; 2004 May; 18(3):187-93. PubMed ID: 15233279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positron emission tomography: quantitative measurement of brain acetylcholinesterase activity using radiolabeled substrates.
    Namba H; Fukushi K; Nagatsuka S; Iyo M; Shinotoh H; Tanada S; Irie T
    Methods; 2002 Jul; 27(3):242-50. PubMed ID: 12183113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
    Irie T; Fukushi K; Namba H; Iyo M; Tamagami H; Nagatsuka S; Ikota N
    J Nucl Med; 1996 Apr; 37(4):649-55. PubMed ID: 8691261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Imaging of brain acetylcholinesterase activity in dementias and extrapyramidal disorders].
    Shinotoh H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):822-5. PubMed ID: 18210807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voxel-Based Acetylcholinesterase PET Study in Early and Late Onset Alzheimer's Disease.
    Hirano S; Shinotoh H; Shimada H; Ota T; Sato K; Tanaka N; Zhang MR; Higuchi M; Fukushi K; Irie T; Kuwabara S; Suhara T
    J Alzheimers Dis; 2018; 62(4):1539-1548. PubMed ID: 29562505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia.
    Hirano S; Shinotoh H; Shimada H; Aotsuka A; Tanaka N; Ota T; Sato K; Ito H; Kuwabara S; Fukushi K; Irie T; Suhara T
    Brain; 2010 Jul; 133(Pt 7):2058-68. PubMed ID: 20558417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of plasma IC50 of donepezil hydrochloride for brain acetylcholinesterase inhibition in monkey using N-[11C]methylpiperidin-4-yl acetate ([11C]MP4A) and PET.
    Shiraishi T; Kikuchi T; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Ota T; Sato K; Hirano S; Tanada S; Iyo M; Irie T
    Neuropsychopharmacology; 2005 Dec; 30(12):2154-61. PubMed ID: 15920507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of cholinergic treatment depends on cholinergic integrity in early Alzheimer's disease.
    Richter N; Beckers N; Onur OA; Dietlein M; Tittgemeyer M; Kracht L; Neumaier B; Fink GR; Kukolja J
    Brain; 2018 Mar; 141(3):903-915. PubMed ID: 29309600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PET study of cholinergic system in the brain].
    Shinotoh H
    Rinsho Shinkeigaku; 1999 Jan; 39(1):33-5. PubMed ID: 10377794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cerebral acetylcholinesterase activity measured with positron emission tomography: procedure, normal values and effect of age.
    Namba H; Iyo M; Fukushi K; Shinotoh H; Nagatsuka S; Suhara T; Sudo Y; Suzuki K; Irie T
    Eur J Nucl Med; 1999 Feb; 26(2):135-43. PubMed ID: 9933347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain acetylcholinesterase activity in mild cognitive impairment and early Alzheimer's disease.
    Rinne JO; Kaasinen V; Järvenpää T; Någren K; Roivainen A; Yu M; Oikonen V; Kurki T
    J Neurol Neurosurg Psychiatry; 2003 Jan; 74(1):113-5. PubMed ID: 12486280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of simplified kinetic analyses for measurement of brain acetylcholinesterase activity using N-[11C]Methylpiperidin-4-yl propionate and positron emission tomography.
    Sato K; Fukushi K; Shinotoh H; Nagatsuka S; Tanaka N; Aotsuka A; Ota T; Shiraishi T; Tanada S; Iyo M; Irie T
    J Cereb Blood Flow Metab; 2004 Jun; 24(6):600-11. PubMed ID: 15181367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The integrity of the cholinergic system determines memory performance in healthy elderly.
    Richter N; Allendorf I; Onur OA; Kracht L; Dietlein M; Tittgemeyer M; Neumaier B; Fink GR; Kukolja J
    Neuroimage; 2014 Oct; 100():481-8. PubMed ID: 24952230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive correlates of alterations in acetylcholinesterase in Alzheimer's disease.
    Bohnen NI; Kaufer DI; Hendrickson R; Ivanco LS; Lopresti B; Davis JG; Constantine G; Mathis CA; Moore RY; DeKosky ST
    Neurosci Lett; 2005 May 20-27; 380(1-2):127-32. PubMed ID: 15854764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study.
    Shinotoh H; Namba H; Fukushi K; Nagatsuka S; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
    Ann Neurol; 2000 Aug; 48(2):194-200. PubMed ID: 10939570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative measurement of cerebral acetylcholinesterase using.
    Blomqvist G; Tavitian B; Pappata S; Crouzel C; Jobert A; Doignon I; Di Giamberardino L
    J Cereb Blood Flow Metab; 2001 Feb; 21(2):114-31. PubMed ID: 11176277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.